1. Foocharoen, C, Watcharenwong, P, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis. 2017; :. doi: 10.1111/1756-185X.13060. PubMed PMID:28296274 .
  2. Daungkum, K, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Thinkhamrop, B, Nanagara, R et al.. Self-assessment of skin tightness severity by scleroderma patients. Int J Rheum Dis. 2016;19 (10):989-995. doi: 10.1111/1756-185X.12879. PubMed PMID:27126197 .
  3. Suebmee, P, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Theerakulpisut, D, Nanagara, R et al.. Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. Am. J. Med. Sci. 2016;352 (2):166-71. doi: 10.1016/j.amjms.2016.04.017. PubMed PMID:27524215 .
  4. Foocharoen, C, Chunlertrith, K, Mairiang, P, Mahakkanukrauh, A, Suwannaroj, S, Namvijit, S et al.. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. Rheumatology (Oxford). 2017;56 (2):214-222. doi: 10.1093/rheumatology/kew216. PubMed PMID:27179107 .
  5. Foocharoen, C, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma. Int J Rheum Dis. 2016;19 (9):913-23. doi: 10.1111/1756-185X.12884. PubMed PMID:27126733 .
  6. Foocharoen, C, Thinkhamrop, B, Mahakkanukrauh, A, Suwannaroj, S, Netwijitpan, S, Sripavatakul, K et al.. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study. J Med Assoc Thai. 2015;98 (11):1082-8. . PubMed PMID:26817178 .
  7. Sumphao-Ngern, P, Foocharoen, C, Boonsawat, W, Mahakkanukrauh, A, Suwannaroj, S, Sae-Oue, U et al.. Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis. Arch Med Sci. 2015;11 (6):1255-60. doi: 10.5114/aoms.2015.56352. PubMed PMID:26788088 PubMed Central PMC4697058.
  8. Foocharoen, C, Pussadhamma, B, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Rheumatology (Oxford). 2015;54 (9):1616-21. doi: 10.1093/rheumatology/kev096. PubMed PMID:25863044 .
  9. Foocharoen, C, Yenrom, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Prevalence and causes of loss to follow-up among patients with systemic sclerosis. J Clin Rheumatol. 2014;20 (8):456. doi: 10.1097/RHU.0000000000000198. PubMed PMID:25417691 .
  10. Foocharoen, C, Suwannachat, P, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Int J Rheum Dis. 2016;19 (3):312-20. doi: 10.1111/1756-185X.12492. PubMed PMID:25293362 .
  11. Foocharoen, C, Mahakkanukrauh, A, Pussadhamma, B, Netwijitpan, S, Suwannaroj, S, Nanagara, R et al.. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?. J Clin Rheumatol. 2014;20 (5):268-74. doi: 10.1097/RHU.0000000000000120. PubMed PMID:25036561 .
  12. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. J Med Assoc Thai. 2014;97 (1):28-35. . PubMed PMID:24701726 .
  13. Kitchongcharoenying, P, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. Asian Pac. J. Allergy Immunol. 2013;31 (4):314-9. doi: 10.12932/AP0305.31.4.2013. PubMed PMID:24383974 .
  14. Mahakkanukrauh, A, Thavornpitak, Y, Foocharoen, C, Suwannaroj, S, Nanagara, R. Features and outcomes of hospitalized Thai patients with pyogenic arthritis: analysis from the nationwide hospital database. Int J Rheum Dis. 2013;16 (4):387-91. doi: 10.1111/1756-185X.12071. PubMed PMID:23992256 .
  15. Foocharoen, C, Thavornpitak, Y, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. Int J Rheum Dis. 2013;16 (1):41-6. doi: 10.1111/1756-185X.12031. PubMed PMID:23441771 .
  16. Netwijitpan, S, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. Clin. Rheumatol. 2013;32 (3):361-7. doi: 10.1007/s10067-012-2131-0. PubMed PMID:23224269 .
  17. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients. Int J Rheum Dis. 2012;15 (5):e90-5. doi: 10.1111/j.1756-185X.2012.01760.x. PubMed PMID:23083053 .
  18. Kunyakham, W, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. Asian Pac. J. Allergy Immunol. 2012;30 (2):152-7. . PubMed PMID:22830295 .
  19. Foocharoen, C, Siriphannon, Y, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Incidence rate and causes of infection in Thai systemic sclerosis patients. Int J Rheum Dis. 2012;15 (3):277-83. doi: 10.1111/j.1756-185X.2012.01728.x. PubMed PMID:22709489 .
  20. Foocharoen, C, Nanagara, R, Suwannaroj, S, Mahakkanukrauh, A. Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment. Int J Rheum Dis. 2011;14 (4):353-60. doi: 10.1111/j.1756-185X.2011.01639.x. PubMed PMID:22004232 .
  21. Foocharoen, C, Nanagara, R, Kiatchoosakun, S, Suwannaroj, S, Mahakkanukrauh, A. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Int J Rheum Dis. 2011;14 (3):282-9. doi: 10.1111/j.1756-185X.2011.01625.x. PubMed PMID:21816025 .
  22. Foocharoen, C, Nanagara, R, Suwannaroj, S, Mahakkanukrauh, A. Clinical features and disease outcomes of undifferentiated arthritis in Thailand. Int J Rheum Dis. 2011;14 (3):e14-21. doi: 10.1111/j.1756-185X.2011.01606.x. PubMed PMID:21816008 .
  23. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. Clin. Rheumatol. 2011;30 (9):1235-40. doi: 10.1007/s10067-011-1744-z. PubMed PMID:21484224 .
  24. Foocharoen, C, Nanagara, R, Foocharoen, T, Mootsikapun, P, Suwannaroj, S, Mahakkanukrauh, A et al.. Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: a 10-year retrospective study. Southeast Asian J. Trop. Med. Public Health. 2010;41 (6):1438-46. . PubMed PMID:21329321 .
  25. Foocharoen, C, Nanagara, R, Salang, L, Suwannaroj, S, Mahakkanukrauh, A. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. J Med Assoc Thai. 2009;92 (2):167-74. . PubMed PMID:19253790 .
  26. Kiatchoosakun, S, Ungkasekvinai, W, Wonvipaporn, C, Tatsanavivat, P, Foocharoen, C, Suwannaroj, S et al.. D-dimer and pulmonary arterial hypertension in systemic sclerosis. J Med Assoc Thai. 2007;90 (10):2024-9. . PubMed PMID:18041419 .
  27. Suwannaroj, S, Mootsikapun, P, Vipulakorn, K, Nanagara, R. Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus. J Clin Rheumatol. 2001;7 (2):83-5. . PubMed PMID:17039101 .
  28. Mootsikapun, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Tuberculous pyomyositis. J Med Assoc Thai. 2003;86 (5):477-81. . PubMed PMID:12859107 .
  29. Mootsikapun, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Quinolones and Salmonella septic arthritis. J Med Assoc Thai. 2002;85 (9):984-9. . PubMed PMID:12450076 .
  30. McMurray, RW, Suwannaroj, S, Ndebele, K, Jenkins, JK. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology. 2001;69 (1):44-58. doi: 48757. PubMed PMID:11641617 .
  31. Jenkins, JK, Suwannaroj, S, Elbourne, KB, Ndebele, K, McMurray, RW. 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. Int. Immunopharmacol. 2001;1 (11):1897-911. . PubMed PMID:11606022 .
  32. Suwannaroj, S, Lagoo, A, McMurray, RW. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. Lupus. 2001;10 (8):562-7. doi: 10.1191/096120301701549697. PubMed PMID:11530998 .
  33. Suwannaroj, S, Lagoo, A, Keisler, D, McMurray, RW. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE). Lupus. 2001;10 (4):258-65. doi: 10.1191/096120301680416940. PubMed PMID:11341102 .
  34. Nanagara, R, Vipulakorn, K, Suwannaroj, S, Schumacher, HR Jr. Atypical morphological characteristics and surface antigen expression of Burkholderia pseudomallei in naturally infected human synovial tissues. Mod Rheumatol. 2000;10 (3):129-36. doi: 10.3109/s101650070019. PubMed PMID:24383589 .
  35. Suwannaroj, S, Elkins, SL, McMurray, RW. Systemic lupus erythematosus and Castleman's disease. J. Rheumatol. 1999;26 (6):1400-3. . PubMed PMID:10381064 .
Search PubMed